Medtronic, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 122   

Articles published

MDT 72.38 +0.30 (0.42%)
price chart
Medtronic profit meets expectations; Covidien deal on track
Nov 18 (Reuters) - Medtronic Inc posted a quarterly profit that was in line with analyst expectations, helped by sales of new heart devices, and said its $42.9 billion purchase of hospital products maker Covidien Plc remains on track to close early ...
Medtronic Sales Rise, Backs Covidien Deal
Sales of Medtronic's implanted cardiac defibrillators, or ICDs, fell 6% to $670 million, down from $713 million a year earlier.
Analysts like Medtronic moves, earnings  Memphis Business Journal (blog)
Related articles »  
See Why Medtronic Stock Is Surging Today
Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. The author wrote this article themselves, and it expresses their own opinions.
Stocks to Watch: Home Depot, Medtronic, SunEdison
SunEdison and clean-power plant subsidiary TerraForm Power Inc.TERP +22.95% are buying Boston-based renewable-energy company First Wind for $2.4 billion, a deal that would make SunEdison the world's largest renewable-energy-development ...
Medtronic Meets 2Q Profit Forecasts
MINNEAPOLIS (AP) - Medtronic Inc. on Tuesday reported earnings of $828 million in its fiscal second quarter. The Minneapolis-based company said it had profit of 83 cents per share.
Related articles »  
Medtronic sets date for shareholder vote on Covidien deal
Fridley-based Medtronic announced earlier this year it would buy Ireland-based Covidien. Some longtime Medtronic shareholders at the company's annual meeting in August objected to the acquisition because they will be stuck with capital-gains taxes ...
Rating firms ponder Medtronic downgrades over new tax rules
The Medtronic Inc. headquarters building stands in Minneapolis, Minnesota, U.S., on Monday, June 16, 2014. Medtronic Inc., the second-largest maker of medical devices, agreed to buy Covidien Plc for $42.9 billion in cash and stock as it transforms into ...
Medtronic offers EU concessions in $43 bln Covidien deal
BRUSSELS Nov 11 (Reuters) - U.S. medical device maker Medtronic Inc has offered concessions in a bid to secure European Union regulatory approval for its $43 billion acquisition of Irish rival Covidien Plc, the European Commission said.
Medtronic (MDT) Reports Escalating Costs For Its Covidien (COV) Deal  Bidness ETC
Medtronic submits concessions for $43B Covidien takeover  Seeking Alpha (registration)
Related articles »  
Medtronic Conference Call Highlights
Medtronic, Inc. (NYSE: MDT) reported its fourth quarter earnings on Tuesday. Shares of the company are up 3 percent.
Medtronic Revenue Grows 5%, Backs Commitment to Covidien Deal
Medtronic's plan to buy Irish health-care-products company Covidien PLC has drawn scrutiny over a tax tactic criticized by U.S.